Activities - how the charity spends its money
Support for those affected by Myelodysplastic Syndrome, ("MDS"), which is a rare blood cancer.
We provide: national & regional meetings with specialist speakers, a website & newsletter, campaigning for access to treatment, a networking service for MDS patients to share experiences & support; cooperate with all UK MDS clinical experts & aim to connect with all UK haematology departments.
Income and expenditure
Data for financial year ending
31 March 2020
Total income: £93,977
Total expenditure: £309,339
Employees with total benefits over £60,000
No employees have total benefits over £60k for this charity
This charity raises funds from the public. Works with a professional fundraiser with an agreement in place. It does not work with a commercial participator.
This charity does not have any trading subsidiaries.
No trustees receive any remuneration, payments or benefits from the charity.